GIL Investments, alongside Thomas Engelen of Akcros Chemicals, have completed an investment into Stanchem International, a UK-based but global supplier of natural and plant-based formulations and ingredients to a wide variety of industrial, agricultural and consumer-focussed sectors.
Stan Chem, which has annual sales of £22m and profits of c.£2m, employs more than 100 people at three sites in Reading, Great Yarmouth and Kingscliffe. The business was founded in 1977 by Paul Styles and Vivien Freeman, who will remain closely involved with the business and work alongside GIL to enable the business to grow and thrive.
Thomas Engelen, non-Executive Chairman of another GIL business, Akcros Chemicals Ltd, has been appointed Chairman of Stanchem and Paul Rohof is appointed as Managing Director.
This transaction represents a significant investment in a sector we see as very exciting and has been led by Thomas Engelen, with whom we have worked closely for many years at Akcros Chemicals. We are looking forward to a bright future for Stan Chem and are keen to get to work alongside the existing team together with Thomas and Paul Rohof to drive the business forward.
GIL remains acquisitive and the team are working on several processes looking at profitable, long-term businesses where we believe we can add value. We are still proud to be privately funded and carry out David Grove’s investment philosophy of supporting good management teams with long-term equity investing.
Quote by GIL Investments Chief Executive Les Litwinowicz